1-20 of 51
Sort by
News

Lower Risk of GVHD With Parous Female Sibling Donors Than With Male Unrelated Donors

Published: 2021
View News titled, Lower Risk of GVHD With Parous Female Sibling Donors Than With Male Unrelated Donors
News

Synthetic Hepcidin Options Safe in Patients With Iron Disorders, But Efficacy Data Still Preliminary

Published: 2021
View News titled, Synthetic Hepcidin Options Safe in Patients With Iron Disorders, But Efficacy Data Still Preliminary
News

Evaluating FT-2102 in IDH1-Mutated AML or MDS

Published: 2021
View News titled, Evaluating FT-2102 in IDH1-Mutated AML or MDS
News

Moxetumomab Pasudotox: An Alternative to Chemotherapy in Hairy Cell Leukemia

Published: 2021
View News titled, Moxetumomab Pasudotox: An Alternative to Chemotherapy in Hairy Cell Leukemia
News

Phase III BFORE Trial: Bosutinib Beats Imatinib for Frontline CML Treatment

Published: 2021
View News titled, Phase III BFORE Trial: Bosutinib Beats Imatinib for Frontline CML Treatment
News

EURO-SKI: Can Patients With CML Stop Tyrosine Kinase Inhibitors?

Published: 2021
View News titled, EURO-SKI: Can Patients With CML Stop Tyrosine Kinase Inhibitors?
News

Presence of Minimal Residual Disease Predicts Relapse and Survival in AML

Published: 2021
View News titled, Presence of Minimal Residual Disease Predicts Relapse and Survival in AML
News

Complete Mutation Clearance Predicts Longer Survival and Lower Relapse Risk in AML

Published: 2021
View News titled, Complete Mutation Clearance Predicts Longer Survival and Lower Relapse Risk in AML
News

Psychiatric Comorbidities of Myeloma Lead to High Health-Care Costs

Published: 2021
View News titled, Psychiatric Comorbidities of Myeloma Lead to High Health-Care Costs
News

FDA Opens Communication Lines Between Drug Makers and Insurers

Published: 2021
View News titled, FDA Opens Communication Lines Between Drug Makers and Insurers
News

First Pegfilgrastim Biosimilar Receives Approval

Published: 2021
View News titled, First Pegfilgrastim Biosimilar Receives Approval
News

Fostamatinib Increases Hemoglobin Levels in Warm Antibody Autoimmune Hemolytic Anemia

Published: 2021
View News titled, Fostamatinib Increases Hemoglobin Levels in Warm Antibody Autoimmune Hemolytic Anemia
News

Higher Complete Response Rates With Polatuzumab Vedotin, Bendamustine, and Rituximab Combo in DLBCL

Published: 2021
View News titled, Higher Complete Response Rates With Polatuzumab Vedotin, Bendamustine, and Rituximab Combo in DLBCL
News

Trump Administration Reveals Plans to Lower Drug Prices

Published: 2021
View News titled, Trump Administration Reveals Plans to Lower Drug Prices
News

Acalabrutinib Induces Durable Response in Patients With Waldenström Macroglobulinemia

Published: 2021
View News titled, Acalabrutinib Induces Durable Response in Patients With Waldenström Macroglobulinemia
News

bb2121: Is CAR T-Cell Therapy Moving to Myeloma?

Published: 2021
View News titled, bb2121: Is CAR T-Cell Therapy Moving to Myeloma?
News

Burnout? What Burnout?

Published: 2021
View News titled, Burnout? What Burnout?
News

Axicabtagene Ciloleucel Moves to Acute Lymphocytic Leukemia

Published: 2021
View News titled, Axicabtagene Ciloleucel Moves to Acute Lymphocytic Leukemia
News

NIH Program Completes Genomic Analysis of 33 Cancer Types

Published: 2021
View News titled, NIH Program Completes Genomic Analysis of 33 Cancer Types
News

Vijay Sankaran Receives Weill Cornell’s Children’s Health Research Award, Scripps Researchers Receive Nearly $3 Million to Study CLL, and more

Published: 2021
View News titled, Vijay Sankaran Receives Weill Cornell’s Children’s Health Research Award, Scripps Researchers Receive Nearly $3 Million to Study CLL, and more